Clinical trials
Terminated Diabetes Mellitus, Type 2 trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 34 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 4 |
| AstraZeneca | 4 |
| Novo Nordisk A/S | 4 |
| Centre Hospitalier Universitaire Dijon | 3 |
| University Hospital, Strasbourg, France | 3 |
| Lexicon Pharmaceuticals | 2 |
| University Hospital, Grenoble | 2 |
| University Hospital, Toulouse | 2 |
| Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 34 |
| Diabetes Mellitus | 6 |
| Cardiovascular Diseases | 2 |
| Diabetic Nephropathies | 2 |
| Heart Failure | 2 |
| Obesity | 2 |
| Renal Insufficiency, Chronic | 2 |
| Acute Coronary Syndrome | 1 |
| Arthritis, Rheumatoid | 1 |
| COVID-19 | 1 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.